What is the relevance of George Akerlof’s ‘Market for Lemons’ theory to India’s corporate R&D ecosystem?

George Akerlof’s ‘Market for Lemons’ explains how information asymmetry drives high-quality products out of the market when buyers cannot distinguish them from low-quality ones. Applied to India’s corporate R&D ecosystem, the theory suggests that when investors cannot accurately assess which firms are genuinely innovating, they discount all firms uniformly. As a result, companies undertaking high-risk, high-quality research are undervalued in capital markets.India’s corporate R&D intensity remains at 0.23% of GDP, significantly lower than global peers. This stagnation is not merely due to risk aversion but also due to the absence of structured innovation disclosures. When R&D pipelines, patent quality, and technological capability are invisible, markets fail to price them correctly. Consequently, firms shift resources toward tangible assets like real estate or plant expansion, which are easier to evaluate.Thus, the ‘lemons’ problem in R&D leads to systematic underproduction of innovation. High-quality innovators exit or scale back, while mediocre or rent-seeking projects survive. Without transparency, markets cannot reward genuine scientific effort, leading to suboptimal national innovation outcomes.

Why is structured R&D disclosure important for improving capital allocation and lowering the cost of capital?

Structured R&D disclosure reduces information asymmetry between firms and investors. When companies provide clear metrics—such as R&D expenditure, patent activity, and Technology Readiness Levels (TRLs)—investors can differentiate serious innovation efforts from superficial claims. This improves pricing accuracy in equity markets.Empirical evidence supports this argument. Brown and Martinsson (2018) show that improved transparency increases R&D intensity by 6–12% in OECD economies. Similarly, mandated disclosures in China’s Shanghai Stock Exchange led to greater innovation among non-state and financially constrained firms. Transparency reassures investors that capital is being deployed efficiently, thereby reducing perceived risk and lowering the cost of capital.Importantly, such disclosure shifts investment toward intangible assets rather than brick-and-mortar expansion. When innovation metrics are visible, firms with strong pipelines receive better valuations, allowing them to raise funds more cheaply. This strengthens India’s transition toward a knowledge-based economy without fiscal expenditure by the state.

How would the proposed Mandatory R&D and Technology Disclosure Standard under SEBI’s LODR framework function in practice?

The proposed Mandatory R&D and Technology Disclosure Standard under SEBI’s LODR Regulations (2015) would not mandate spending levels but require structured reporting across five dimensions:R&D expenditure (capital and revenue) with segment-level clarityPatent activity including filings, grants, and expirationsTechnology workforce compositionTechnology Readiness Levels (TRLs) of major projectsInnovation turnover—revenue from products introduced in the last five yearsThese metrics are standard globally but largely absent in India. A phased implementation—two years of voluntary disclosure followed by mandatory compliance—would help firms adapt and improve data quality.Crucially, the framework avoids revealing proprietary secrets. Instead, it provides standardised, comparable indicators enabling analysts to assess innovation depth. By improving transparency without directing technological pathways, it preserves market freedom while correcting structural information failure.

Critically analyse the potential benefits and risks of mandatory R&D disclosure in innovation-driven sectors such as pharmaceuticals.

Mandatory R&D disclosure offers multiple benefits. It improves market discipline, enhances investment efficiency, and reallocates capital toward high-quality scientific projects. Evidence from Korea’s K-IFRS reforms shows that visible intangible disclosures encouraged firms to increase R&D investment. Transparency also enables ‘portfolio purification,’ where weak or duplicative projects are terminated early.However, there are risks. In sectors like pharmaceuticals, disclosure can function as a Bayesian signal. Competitors learn about pipeline overlaps and project timelines, potentially intensifying competitive pressure. As observed in China, weaker firms may terminate projects when they realise they are dominated by stronger players. This could reduce the number of long-shot or breakthrough innovations.Yet, this pruning may improve overall efficiency and safety. By reallocating capital toward stronger scientific bets, transparency enhances social welfare. The challenge lies in designing disclosure norms that balance competitive sensitivity with informational clarity. Thus, while risks exist, the net effect is likely to be positive if implementation is carefully calibrated.

What international experiences demonstrate the impact of innovation disclosure on R&D performance?

Several international cases illustrate the transformative role of innovation disclosure. In OECD economies, improved transparency has been linked to measurable increases in R&D intensity. Brown and Martinsson’s study found a 6–12% rise in R&D spending following enhanced disclosure norms, particularly in equity-dependent sectors.China provides a compelling example. Mandated disclosures on the Shanghai Stock Exchange significantly boosted innovation among private and financially constrained firms. The transparency mechanism encouraged firms to improve project quality and rationalise portfolios. Similarly, Korea’s adoption of intangible disclosure norms under K-IFRS strengthened market discipline and raised R&D investment.These examples show that disclosure is a non-distortionary policy instrument. It does not require subsidies or direct intervention but relies on market forces to reward innovation. For India, adopting similar standards could catalyse innovation-led growth while preserving fiscal prudence and competitive neutrality.

Search Today Mains CSAT

India's Urgent Call for R&D Disclosure Standards

Implementing structured R&D reporting could enhance transparency and accelerate innovation across sectors in India.

Gopi

•March 4, 2026•5 mins read

Mandatory R&D disclosure can unlock innovation by making markets value quality research

George Akerlof’s 1970 paper The Market for Lemons demonstrated how markets fail when buyers cannot distinguish between high- and low-quality goods. In such situations, average pricing drives high-quality products out of the market. This principle applies beyond consumer goods and extends to financial markets and innovation ecosystems. In...

India's Urgent Call for R&D Disclosure Standards

Practice Questions

No Prelims Content Available

Attribution

Comments (0)